Ontology highlight
ABSTRACT: Background
Treatment with direct-acting antivirals (DAAs) in patients with chronic hepatitis C infection leads to partial restoration of soluble inflammatory mediators (SIMs). In contrast, we hypothesized that early DAA treatment of acute hepatitis C virus (HCV) with DAAs may normalize most SIMs.Methods
In this study, we made use of a unique cohort of acute symptomatic hepatitis C patients who cleared HCV with a 6-week course of ledipasvir/sofosbuvir. Plasma samples were used for proximity extension assay measuring 92 proteins.Results
Profound SIM alterations were observed in acute HCV patients, with marked upregulation of interleukin (IL)-6 and CXCL-10, whereas certain mediators were downregulated (eg, monocyte chemoattractant protein-4, IL-7). During treatment and follow-up, the majority of SIMs decreased but not all normalized (eg, CDCP1, IL-18). Of note, SIMs that were downregulated before DAA treatment remained suppressed, whereas others that were initially unchanged declined to lower values during treatment and follow-up (eg, CD244).Conclusions
Acute hepatitis C was associated with marked changes in the soluble inflammatory milieu compared with both chronic hepatitis patients and healthy controls. Whereas early DAA treatment partly normalized this altered signature, long-lasting imprints of HCV remained.
SUBMITTER: Khera T
PROVIDER: S-EPMC9417126 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature
Khera Tanvi T Du Yanqin Y Todt Daniel D Deterding Katja K Strunz Benedikt B Hardtke Svenja S Aregay Amare A Port Kerstin K Hardtke-Wolenski Matthias M Steinmann Eike E Björkström Niklas K NK Manns Michael P MP Hengst Julia J Cornberg Markus M Wedemeyer Heiner H
The Journal of infectious diseases 20220801 3
<h4>Background</h4>Treatment with direct-acting antivirals (DAAs) in patients with chronic hepatitis C infection leads to partial restoration of soluble inflammatory mediators (SIMs). In contrast, we hypothesized that early DAA treatment of acute hepatitis C virus (HCV) with DAAs may normalize most SIMs.<h4>Methods</h4>In this study, we made use of a unique cohort of acute symptomatic hepatitis C patients who cleared HCV with a 6-week course of ledipasvir/sofosbuvir. Plasma samples were used for ...[more]